Navigation Links
Qteros Management to Present at Upcoming Conferences in May
Date:4/28/2011

MARLBOROUGH, Mass., April 28, 2011 /PRNewswire/ -- Qteros, Inc., the developer of a unique and highly efficient Consolidated Bioprocessing (CBP) platform for the lowest-cost production of cellulosic ethanol, today announced its plans to present at various industry conferences throughout the month of May.

Kevin A. Gray, Ph.D., Senior Vice President and Chief Scientific Officer for Qteros, will deliver an oral presentation at the 33rd Symposium on Biotechnology for Fuels and Chemicals being held at the Sheraton Seattle, Washington. His presentation, "Technology Development and Scale-up of the Production of Lignocellulosic Ethanol using the Microbe Clostridium phytofermentans" will be presented during Session 9: Biofuels and Biorefinery Economics and Sustainability on Tuesday, May 3, 2011 at 1:00pm PDT.

Mick Sawka, Qteros' Senior Vice President of Commercial Development and Engineering, will also present on May 3, 2011 at Thomson Reuters' Open Innovation Seminar. The presentation is scheduled for 8:00am EDT and will be held at Thomson Reuters' offices in Boston, MA.

Dr. Gray will participate in the 2011 World Congress on Industrial Biotechnology & Bioprocessing in Toronto, Ontario, Canada. On Monday, May 9, 2011 at 8:45am EDT, Dr. Gray will deliver a presentation entitled, "Plant Cell Wall Degrading Micro-Organisms as Biocatalysts for Biofuels and Bio-Chemicals Production."  On Tuesday, May 10, 2011, at 9:00am EDT, Dr. Gray will moderate a panel entitled, "Engineering Low Cost Feedstocks to Value-Add Bio-chemicals." He will deliver a presentation during this panel discussion entitled, "Clostridium phytofermentans as an Inexpensive Sugar Platform for Biochemicals."

About Qteros, Inc.
Qteros' mission is to accelerate the global commercialization of large-scale, lowest-cost cellulosic ethanol production. Qteros has teamed with a core group of world-class strategic partners that complement and leverage our advanced microbiology and process engineering expertise. Working closely with its strategic partners, Qteros expects to rapidly scale its highly efficient, lowest-cost Consolidated Bioprocessing (CBP) platform for converting non-food biomass into biofuels. Qteros is funded by leading investors in the alternative energy industry including, among others, Venrock Associates, Battery Ventures, BP AE Ventures, Soros Fund Management LLC, and Valero Energy Corporation. For more information, please visit www.qteros.com.

CONTACT:
Susan Hager
VP Corporate Communications & Government Affairs
shager@qteros.com
(508) 251-6339


'/>"/>
SOURCE Qteros, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Qteros Management to Present at Alternative Energy Investment Banking Conferences
2. Qteros Management to Present at Notable Alternative Energy Conferences in February
3. Qteros and Praj Industries Announce Broad Strategic Partnership to Accelerate Global Commercialization of Cellulosic Ethanol
4. Qteros and UMass Amherst Announce the Issuance of a U.S. Patent for Production of Ethanol From a Unique Microorganism, the Q Microbe(TM)
5. Biofuels Technology Leader Qteros Names Mick Sawka Vice President, Business Development
6. Biofuels Technology Leader Qteros Names Industry Veteran John McCarthy President and Chief Executive Officer
7. Cellulosic Biofuels Leader Qteros Adds Key Positions
8. Qteros Employees Planting Special Trees in Celebration of International Day of Climate Action, October 24, 2009
9. Conflict of Interest Management System Selected by Henry Ford Health System
10. Best Practices, LLC Showcases Its Expertise in Customer Relationship Management
11. SPX Announces Acquisition of B.W. Murdoch Ltd, Broadening Process Engineering and Project Management Capabilities in New Zealand and the Asia Pacific Region
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... A person commits a crime, and the detective ... the criminal down. An outbreak of foodborne illness ... (FDA) uses DNA evidence to track down the bacteria that ... It,s not. The FDA has increasingly used a complex, cutting-edge ... illnesses. Put as simply as possible, whole genome sequencing is ...
(Date:6/23/2016)... MONICA, Calif. , June 23, 2016  The Prostate Cancer Foundation ... pioneer increasingly precise treatments and faster cures for prostate cancer. Members of the ... institutions across 15 countries. Read More About the Class ... ... ...
(Date:6/23/2016)... ... 2016 , ... Supplyframe, the Industry Network for electronics hardware ... . Located in Pasadena, Calif., the Design Lab’s mission is to bring together ... built and brought to market. , The Design Lab is Supplyframe’s physical representation ...
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
Breaking Biology Technology:
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. and ... business relationship that includes integrating Syngrafii,s patented LongPen™ ... project. This collaboration will result in greater convenience ... credit union, while maintaining existing document workflow and ... ...
(Date:6/1/2016)... YORK , June 1, 2016 ... Technology in Election Administration and Criminal Identification to Boost ... to a recently released TechSci Research report, " Global ... By Region, Competition Forecast and Opportunities, 2011 - 2021", ... 24.8 billion by 2021, on account of growing security ...
(Date:5/9/2016)... 2016 Elevay is currently known ... freedom for high net worth professionals seeking travel for ... connected world, there is still no substitute for a ... sealing your deal with a firm handshake. This is ... advantage of citizenship via investment programs like those offered ...
Breaking Biology News(10 mins):